April 22

Forgotton Cure 3

One of the biggest problems in phage therapy has been in the approval process.   Describe the trouble surrounding FDA approval and recommend some suggestions to improve the process of phage therapy approval.

The approval process for any drug or treatment is extremely tedious and complex. The FDA approval process has a structure so complicated that one needs experts to be able to complete this process. Besides that, the FDA also has a high standard for evidence and definitive results, which is extremely difficult to meet due to the limitations on time and resources. It requires years and millions of dollars to get through the approval process of the FDA to even begin human trials and is even worse for approval for the market. In terms of phage therapy, increasing the awareness of this treatment among scientist and doctors would help improve the process. This will allow the FDA to have pool of experts to consult with on the topic, which decrease the amount of miscommunication that may exist between the companies and the FDA. Increase of funding from the government would also help these companies as it will give them more resources, which will allow them to sustain themselves while they wait during the approval process.

April 22

The Forgotten Cure 3

Prompt: As a scientist, describe the main experiment you would like to see performed before phage therapy is approved for human use. What are the risks involved with using phage therapy?

 

As mentioned in The Forgotten Cure, phage therapy has hit many roadblocks in the process of becoming approved for medical use in the United States. Some of the major risks involved with using phage therapy are septic shock, bacterial transduction, as well as the concern of bacteriophage being lysogenic. With septic shock, many bacteria house endotoxins within themselves which can be released into the patient’s body when lysed by the bacteriophage, which can lead to dangerously low blood pressure. In bacterial transduction, the phage has the possibility of exchanging genes with the bacterium and “turning” the bacterial cell into a deadly and pathogenic one. An example is the strains of E. coli 0,157. The main experiment I would like to see performed before phage therapy is approved is decreasing the likelihood that any of these mentioned risks from happening.

In the book, Ramachandran had the idea that if they would be able to block the gene that codes for endolysin, then they could create a phage that kills its prey but never lyse the cell, therefor solving the problem of septic shock in patients. He partnered with Sriram and Bharati Padmanabhan to test his hypothesis using a plasmid to inactivate the endolysin. His hypothesis was successful in that no plaques were formed, but the E. coli bacteria were inactive. This discovery also led Ramachandran to hypothesize that this process could be used to create more effective vaccines. In current vaccinations, the bacteria are killed using intense heat or formaldehyde solution which can denature or destroy many of the antigens on the surfaces of the bacteria. In the study conducted by Bharathi, the vaccinated group all survived, while 80% of the mice not vaccinated died. Such discoveries and research is slowly moving bacteriophage therapy towards medical use, but is not yet a 90-100% success rate.

I believe that bacteriophage research is approaching the threshold of being approved by the FDA for commercial use, but there are still many limitations or “grey areas” in which we have no research to back our hypothesis. Such a grey area is that how will the FDA and general public react to the bacteriophages being left in the patients body after treatment? As of right now, there is no procedure to remove the bacteriophage from the body after administration. Will the FDA approve bacteriophage even though they’re harmless to other “helpful” bacteria found throughout the body and will be degraded after some time? I believe that although there are still many questions that need to be answered, we need to be able to realize that the use of antibiotics have created superbugs that are more deadly than ever and bacteriophage therapy provides a possible solution to these bacterium.

April 20

The Forgotten Cure 3

Prompt

As a scientist, describe the main experiment you would like to see performed before phage therapy is approved for human use. What are the risks involved with using phage therapy?

Many experiments has been performed in the past through other animals to see the effectiveness of phage therapy. In The Forgotten Cure,  Kuchment presented two examples of testing that was done to combat salmonella and e. coli. In 2002, Perdue headquarters began testing phages on salmonella. Salmonella began a huge problem that was found in uncooked chicken meat. They took the eggs, baby chicken, and adult chickens and treated them with phages. With the eggs, they injected bacteriophages and sprayed phages on the baby/adult chickens. As a result so far, they found that phage therapy was more effective compared to other methods for reducing salmonella in chickens.  GangaGen also tested out phages to see how well it would help e. coli in the cow’s stomachs. Their findings showed that the phages helped kill the bacteria and the viruses were flushed out of the cow’s intestines. According to The Forgotten Cure, the only FDA approved medical use of phage therapy were for patients with AIDS.

If phage therapy were to come back within later this year or in the future, I believe it would be better for human trails to start with other diseases other than AIDS. Other diseases, such as meningococcal meningitis, can be treated with vaccines, but the vaccines doesn’t work for all types of meningococcal disease, just a few. Although AIDS is a serious health concern, but phage therapy can help diseases that are rare or more serious compared to AIDS. Meningococcal disease affects the brain and spinal cord, which is arguably one of the most important parts for humans to live. Once FDA approves phage therapy for all diseases on humans, I would expect to see experiments first done through other animals that have a certain type of disease, and test out different forms of treatment (oral, injections, sprays). The treatments can be given at a certain time interval and results can be recorded until the animals are free from the disease. How long the treatment takes can be recorded and compared with other types of treatments. Once plenty of experiment done through other animals, human trails can start.

There are lots of risks that can happen during a human trail. There is a chance that even though the trails done by other species worked out well doesn’t necessarily mean that it would work for humans. For example, thalidomide is a drug that was used to help pregnant women relieve nausea. Through testing on rats, it showed no negative effects on the pregnant rat. FDA approved it to use on humans, but sadly, the babies born had physical defects such as missing limbs. FDA took back the approval and stated no pregnant women should take thalidomide. Since there are evidence that not all testing on animals would mean the same result for humans, but there has been a few experiments of phage therapy done on humans mentioned in The Forgotten Cure, when the dysentery patients were treated with phages and showed improvement in health.

April 20

Independent Research Project 4/17/19

Rationale

Today we will look more into our independent research project and hopefully discover a reason for why the %GC in AM cluster phages are significantly lower than that of Arthrobacter.

Procedure

  • Each group member read a large portion of review articles to see if there was a reason why some bacteriophage %GC content was significantly lower than that of their host.
  • We began to see if the trends were present in Arthrobacter using NCBI Blast, PhagesDB, and Phamerator

Results

We found from article reading that horizontal gene transfer is a large reason for why the %GC can differ between host bacteria and their bacteriophage. Lucy found that Staphylococcus had a reportedly low %GC and after using NCBI Blast, it was found that gene 97 in NapoleonB had a CDD hit for Staphylococcus. Gene 98 in Mudcat also had a hit.

Conclusions/Next Steps

Next, we will research more into horizontal gene transfer and if it played a role in the low %GC of other genes.

April 20

Independent Research Project 4/15/19

Rationale

Today we aimed to analyze more %GC and %GC3 content of AM phages and dive more into our independent research project question.

Procedure

  • Reasons for why there was a lower %GC content in AM phages were sought after, as the percent difference is approximately 20% between %GC of Arthrobacter sp ATCC 21022
  • It was decided that the difference between the %GC content in AM Arthrobacter phages and Arthrobacter would be researched as we proceeded for further questioning.
  • An abstract was devised.

Results

There were no notable results from today’s research, as the course of the project changed.

Conclusion/Next Steps

Next, we will research more into our question and investigate the probable differences.

April 20

The Forgotten Cure Part 3

Phage therapy needs to be beneficial for the patient. Potential side effects, such as: phages causing bacterial toxins to spread during lysis, phages mutating and then start harming good bacteria, and phages transforming bacteria to become more anti-resistant, should be addressed before phage therapy receives approval for human use. Along with these risks, other factors that should be considered when using phage therapy include which phage components are manipulated, the pathway of administration, and best practices for ensuring patient recovery. One main experiment that should be performed before phage therapy is approved for human use would investigate ways to make phage therapy the most beneficial and safe for use. With this in mind, I propose an experiment that specifically examines what would be administered to patients and would answer the question of what phage therapy design would ensure patients with the best recovery with the lowest amount of risk.

In Kuchment’s The Forgotten Cure, many phage therapy companies have designed different therapies to be administered. These companies therapies can be divided into the categories of whole-phage focused or “single biological entity” focused (98). Intralytix uses the whole-phage focused approach when they created a multi-lytic phage cocktail. The FDA opposed their work since they had no reliable method of ensuring only lytic phages were present in the cocktail. Also, the VRE cocktail was only tested on mice which are not immunocompromised to VRE, and company findings did not report the speed and the effects of mutations. Shifting towards component-focused therapies, GangaGen addressed the problem of determining whether the phage is virulent or temperate by removing the its endolysin, a protein responsible for cleaving the bacterial host’s peptidoglycan wall. Ramachandran, the founder of GangaGen, hypothesized that “without a ‘burst,’ no toxins or phages would be released into the patient’s body. The fewer the number of phages, the lower the chance that a virus would swap genes with a bacterial cell” (94). In 2001, an experiment was performed using phages without endolysins which resulted in inactive E. coli and no plaques. Another protein GangaGen looked into was tail proteins responsible for the initial hole allowing for DNA to be transferred into the bacterial cell. Their idea was to have the phages create the initial hole but not allow them to seal it back up. It was hypothesized since there was “no DNA going in to repair the hole, so it remains open, and eventually the cell dies because the membrane collapses” (110). Later, this phage tail protein was combined with lysostaphin, a protein that binds and kills bacterial cells, to create the drug StaphTame. Fischetti’s private company decided to abandon using phages for their enzymes.

With the creation of many different phage therapies, an experiment should look into comparing the effectiveness of therapies to each other. Each group would receive one of the following phage therapies: singled lytic phage cocktail, Intralytix’s multi-phage cocktail, GangaGen’s phage tail protein, StaphTame, Ramachandran’s endolysin-less phages, Fischetti’s phage enzymes, or no treatment, which would serve as a control. Also, the experiment should consider having an endolysin cocktail group to determine its effectiveness when compared to the edited phage tail proteins. Another set of groups should receive an antibiotic paired with one of the other therapies. Multiple trials would be performed on different organisms. Many control variables, such as the bacterial host used for infection and the way and rate of administration, would remain consistent among all groups to provide reliable results. This experiment would record the amount of infection and any side effects over the course of the experiment. The results from this experiment would reveal which therapy out of the ones mentioned in The Forgotten Cure would be the most beneficial and safest to use.

April 19

APRIL 15TH AND 17TH- LABS

  • APRIL 15TH 2019
  • OBJECTIVE: 
    • Create a document with all the sequences that need to be run through data bases 
    • Create a background for project 
  • PROCEDURE:
    • A document was created and the gene for the terminase of a phage belonging to each of the following clusters was created:
    • AU1 AU2 AU3 AW BI1(bing) BI2 BI3 BI4 CC DJ EL  
    • A background was written for the project
  • RESULT:
    • Introduction (Background Information)
    • Horizontal gene transfer (HGT) is the transfer of genes from organism to another in- the gene is being passed along horizontally across a generation 
    • Occurs between bacteria and bacteria, or virus and bacteria 
    • Is a crucial part in antibiotic resistance 
    • Can be used to show ancestry between viruses, to look at genetic similarities 
    • Phamerator is a map of the genomes of phages, and lines are drawn across the gene in order to show synteny, or similarities between phages 
      • https://www.nature.com/articles/445369a
  • CONCLUSION: 
    • Document was created 
  • FUTURE STEPS: 
    • Finish abstract 
  • APRIL 17TH 2019
  • OBJECTIVE: 
    • Write parts of presentation for project (abstract, methods used, results etc.)
  • PROCEDURE:
    • A document on google docs was shared with group members 
  • RESULT:
    • Title
    • Evidence for Supercluster 46041 and others.
    • Guiding Question
    • Our objective is to compare pham 46041 DNA polymerase and observe the patterns that can be derived from cross-analysis. 
    • Abstract 
    • The Horizontal gene transfer is an evolutionary method that promotes genetic diversity through the passing of genes. A result of the mosaic model within populations of bacteriophage cells is the common appearance of conserved domain groups that are present across different clusters. The smaller size of bacteriophage genome allows the presentation of modules, a group of specialized genes that are localized within the same region. The analysis of a conserved modules in clusters that are associated with the DNA polymerases was conducted in the experiment. Through the tool Phamerator, we observed the phage genome map to determine the range of modules and identify the clusters needed to detect the sequence similarity. We also used RaptorX to observe the protein-protein interaction similarity between the gene modules and constructed phylogenetic trees that visually compares the multiple clusters of actionobacteriophages and demonstrate the shared evolutionary relationship with the DNA Polymerase gene. We have discovered evidence of common modules existing across multiple seemingly dissimilar clusters. This leads us to believe that these clusters all belong to a larger group. 
    • Phage genome have a typically smaller genome that can be analyzed after isolation and characterization through bioinformatic tools such as Phamerator, the construction of a phylogenetic tree based sequence similarity for a specific protein product, and the structure analysis of analogous sequences of the same pham.
    • List of tools used: Tmhmm, raptor X Structure Prediction, Raptor X Deep Align, Jmol,Dendroscope,, HGTree, Phamerator
    • Introduction (Background Information)
    • Horizontal gene transfer (HGT) is the transfer of genes from organism to another in- the gene is being passed along horizontally across a generation 
    • Occurs between bacteria and bacteria, or virus and bacteria 
    • Is a crucial part in antibiotic resistance 
    • Can be used to show ancestry between viruses, to look at genetic similarities 
    • Phamerator is a map of the genomes of phages, and lines are drawn across the gene in order to show synteny, or similarities between phages 
    • https://www.nature.com/articles/445369a
    • Types of Data Collected
    • Protein structure comparison, protein and dna sequences from different clusters, Phylogenetic tree, 
    • Results (to date)
    • Supercluster 46041: AM, AW, AU, BI, CC, DJ, EL
    • Supercluster 45806: AZ, BB, BJ, BL, EB, EH
    • Conclusions (if any have been drawn)
    • For gene 60,  TMHMM results show it is a transmembrane protein. There also shows evidence for synteny in transmembrane call in EL phage. Each transmembrane protein is structurally very different, but is made out of a group of alpha helices then a chain of amino acids then a beta pleated sheets.
    • For gene 61, there also seems to have a G5 domain. Blasted against actinobacteria and resulted in a streptomyces hit with a decent e value. The hit contained 3 conserved domains one of which aligned with the amino acid sequence hit. When comparing visual structures the predicted protein structure matches a typical g5 protein structure.
  • CONCLUSION: 
    • Document was created 
  • FUTURE STEPS: 
    • Create phylogenetic tree and continue collecting data
April 19

Individual Project 4/17/19

Rationale: write abstract and continue comparing protein structures

Process:

  1. wrote abstract
  2. selected phages and entered amino acid sequences for their TMPs into raptorX

Results:

Abstract:

Tape measure proteins (TMPs) help determine bacteriophage tail length and facilitate DNA transit into the bacterial cell during infection [2]. Tail length is a key characteristic for classifying a bacteriophage into a tail morphology family (Myoviridae, Siphoviridae, or Podoviridae), and therefore TMPs play a role in determining tail morphology [2]. Arthrobacter phage TMPs are highly conserved in each phage cluster, and it has been noted that arthrobacter Myoviridae phage seem to have an abnormal number of similarities to phages in the Siphoviridae family [1].  This experiment was conducted to determine if Arthrobacter phage TMPs contain any conserved structural or genetic domains within each tail family tested (Myoviridae or Siphoviridae), and to determine if there is any consistent conservation found throughout all Arthrobacter phage TMPs. This was determined bioinformatically by scanning the amino acid sequences of 43 randomly selected Arthrobacter phage TMPs for motifs or other similarities in addition to comparing hypothetically folded TMPs. The distances between the atom backbone of the proteins were used to calculate the root-mean-square distance (RMSD) in order to compare two different structures. In effort to further characterize NapoleonB, each TMP was aligned against NapoleonB’s TMP.*** Preliminary results suggest at least one conserved motif between all TMPs. The protein structures also seem to suggest at least visual similarities between Myoviridae TMPs with more data to be collected. Based on the avaliable data, it appears that TMPs vary widely with a few key areas of similarity that can be further researched.  

***Results are unfinished  

Next Steps:

TM-align all folded proteins with NapoleonB’s structure

April 19

Individual Project 4/15/19

Rationale: Create outline for project and compare different protein structures

Process:

  1. Lucy and I planned out what we thought we needed to do to complete project
  2. began comparing structures using TM-align and chose different phages fold the TMP of
  3. began testing to see what the fastest and easiest way to fold lots of proteins is

Results:

Outline:

Title Comparison of Tape Measure Proteins in Siphoviridae and Myoviridae Tail Families Using Arthrobacter Phage

Guiding Question: What distinguishes tape measure proteins across Siphoviridae and Myoviridae tail families in Arthrobacter Phage and are there conserved domains?

Abstract:

  • TMPs play a major role in determining phage tail families and how phage infect their hosts
  • Amino acid sequences for arthrobacter phage TMPs were compared to find regions of similarity or difference to examine whether or not there is conservation between Myoviridae and Siphoviridae TMPs
  • Hypothetical proteins structures were generated to compare the structural differences in TMPs to see if structural components were conserved even if amino acid sequences were not
  • ***We don’t have fully fleshed out conclusion or results but we will alter our abstract as needed

List of tools used:

  • I-tasser
  • Clustal Omega
  • MEME Motif
  • TM align

Introduction (Background Information):

  • Tape Measure Proteins (TMPs) help control tail length/type and how a phage infects its bacterial host
  • Arthrobacter phage cluster appear to exist in all three tail types (Podoviridae, Myoviridae, and Siphoviridae) but Podoviridae do not call TMPs
  • Previous research suggests that in arthrobacter phage myoviridae and siphoviridae TMPs are more similar than in phage that infect other hosts
  • Previous research suggests that structure is conserved more than the specific amino acid sequence
  • Protein structures can be compared statistically by finding the root-mean-square deviation (RMSD) or the measure of the average distance between the backbone atoms of superimposed proteins

Types of Data Collected:

  • Computer generated folded proteins
  • MEME motifs showing conserved motif domains
  • Clustal Omega amino acid sequence comparisons
  • TM alignments that give numerical comparisons of protein structures

Results (to date):

  • Amino acid sequences for TMPs in each cluster appear to be highly conserved (identical or only 2-3 amino acid differences) – found using clustal omega comparisons
  • Amino acid sequences for TMPs in each tail family do not appear to be highly conserved but the type of amino acid (as determined by clustal omega color coding) appear to be more conserved – found using clustal omega comparisons
  • Have started to model predicted protein structures and myoviridae proteins are visually more similar to each other than to siphoviridae proteins
    • However: NapoleonB (sipovirade) and Chubster (myoviridae) are more mathematically similar than Chubster and Sonny (myoviridae)
  • Structures are scoring relatively low in similarity and tend to fall in “random structural similarity” category
  • Using MEME motif software several cross cluster but within tail family motifs have been identified in addition to two motifs that seem to appear in both Myovirade and Sipovirade phage

Conclusions (if any have been drawn):

  1. TMPs are highly conserved
  2. Preliminary data seems to suggest that structure is more conserved than amino acid sequences
  3. There are motifs that contain regions of highly conserved amino acids or amino acid types suggesting that these maybe the conserved domains (or as close as TMPs get)

 

Decided to go with raptorX because while it may not be as accurate, it produces foldings at a much higher rate so using it allows us to have actual data to work with.

 

Next Steps:

Continue folding all 43 proteins and compare them all to NapoleonB and then create a scatter plot of RMSD scores

April 19

4-17-19 — Abstract and Final Data Collection

Abstract and Final Data Collection

Date: 4-19-19

  • Rationale
    • The rational for this lab is to finish gathering data to use for our independent research project as well as write an abstract for the project.
  • Procedure
    1. DNAMaster was used to determine the start codon used for each gene by each phage in the AU cluster.
    2. Findings were recorded on a Google Sheets page and tendencies were calculated.
    3. The group worked together on a abstract for the project, functioning as a summary and introduction to our research.
  • Results
    • Start codons are nucleotide sequences that are found at the beginning of protein-coding genes of DNA. In bacteriophage, these start with the base pairs ATG, GTG, or TTG. Generally, ATG and GTG codons are used at the same frequency, and TTG is used in 7% of cases. This study aims to discover trends between this start-codon tendency and evolutionary relationships between phages within the clusters AM, AQ, AR, and AU. As phage genomics is a recently repopularized field, not much is known about them or how they work. If trends like these are discovered, we can more easily characterize and group phages into subclusters, which in turn would allow future analysts to perform more focused research. Data was gathered using the database PhagesDB and was recorded and expressed using Microsoft Excel, DNAMaster, and SplitsTree4. Start codon preferences were calculated on a spreadsheet and compared to the unrooted phylogenetic trees created with SplitsTree. Our results were inconclusive in regard to a trend between start-codon preferences and evolutionary relatedness being useful as subclustering criteria. However, an interesting trend was discovered in the clusters studied. In each cluster, there is a cluster-specific, highly conserved pattern of start-codon usage at specific locations within the genome that span four to five genes. Although our results were inconclusive, if a study were to recreate ours with data analysis focused on phage within a chosen geographical area, it’s possible that a trend could emerge between start-codon tendency and relationships of phages discovered in this close proximity.
    • The following is an example of the start codons used by CapnMurica, an AU phage.
  • Future Plans
    • The next step is to continue to compare the data we’ve collected and search for trends or surprising discoveries.